Search results

Slaughter and May has advised Cathay Pacific Airways Limited on its acquisition of Hong Kong Express Airways Limited Cathay Pacific Airways Limited on its proposed acquisition of Hong Kong Express Airways Limited Slaughter and May, Hong Kong, advised Wing Tai Properties Limited on the annual update of the US$1 billion Medium Term Notes and Securities Programme Slaughter and May, Hong Kong, advised Wing Tai Properties Limited on the annual update of the US$1 billion Medium Term Notes and Securities Programme Slaughter and May advised ISS on the issuance of notes due 2026 Slaughter and May advised ISS on the issuance of notes due 2026 Slaughter and May is advising CRH plc on the sale of its European distribution business to private equity funds managed by Blackstone CRH plc on the sale of its European distribution business to private equity funds managed by Blackstone Slaughter and May is advising Ocado in connection with its new customer fulfilment centre in Purfleet Ocado in connection with it new customer fulfilment centre in Purfleet Slaughter and May is advising Thomas Cook Group plc - proposed recapitalisation plan Slaughter and May is advising Thomas Cook Group plc - proposed recapitalisation plan Slaughter and May is advising Petrogas and HitecVision on their proposed acquisition of certain of Total’s UK oil and gas assets Slaughter and May is advising Petrogas and HitecVision on their proposed acquisition of certain of Total’s UK oil and gas assets Slaughter and May advised Prudential plc on its issuance of Resettable Dated Tier 2 Notes Prudential plc on its issuance of Resettable Dated Tier 2 Notes Slaughter and May is advising Investindustrial on the possible partial cash offer for shares in Aston Martin Slaughter and May is advising Investindustrial on the possible partial cash offer for shares in Aston Martin Slaughter and May, Hong Kong, advised BVCF Management, as a Series B investor, in relation to the US$325 million series B financing in BioNTech SE Slaughter and May, Hong Kong, advised BVCF Management, as a Series B investor, in relation to the US$325 million series B financing in BioNTech SE